Urology Times

Study compares PSMA-PET radiopharmaceuticals in prostate cancer recurrence

Oct 12, 2026 · 0:03:53

Listen to Episode

✨ AI Summary

Dr. Andrews reviews PSMA-PET radiopharmaceuticals for prostate cancer.
BED-PSMA-411 compares detection rates and urinary excretion.
Findings aid in identifying recurrent prostate cancer.

Guests on This Episode

JM

Jack R. Andrews, MD

1 podcast appearance

More from Urology Times

When surgery may be needed for prolonged ischemic priapism

Oct 12, 2026 · 0:02:34

How can urologists separate personalized medicine from marketing?

Oct 9, 2026 · 0:04:29

Why ctDNA serves as a rule-out in NeoBLAST's response assessment

Oct 8, 2026 · 0:06:56

How should urologists coordinate IVF bladder symptom care?

Oct 8, 2026 · 0:05:25

View all episodes →